Merck Annual Report 2001
14 of 15
Previous Cover Next
Profile Financial Highlights Products Letter Breakthroughs Caring Financials Management Corporate Info
Management Committee
Management Committee
Left to right,

Paul R. Bell, 56, president, Human Health – Asia Pacific since 1997.

Judy C. Lewent, 53, executive vice president since 2001 and chief financial officer since 1990.

David W. Anstice, 53, president, Human Health – The Americas since 1997.

Kenneth C. Frazier, 47, senior vice president and general counsel since 1999.
Richard T. Clark, 56, president, Merck-Medco Managed Care, L.L.C., since 2000.

Raymond V. Gilmartin, 61, chairman, president and chief executive officer since 1994.

Edward M. Scolnick, M.D., 61, executive vice president, science and technology, and president, Merck Research Laboratories
since 1993.

Bernard J. Kelley, 60, president, Merck Manufacturing Division since 1993.
Wendy L. Yarno, 47, senior vice president, Human Resources since 1999.

Per Wold-Olsen, 54, president, Human Health – Europe, Middle East and Africa since 1997.

Bradley T. Sheares, Ph.D., 45, president, U.S. Human Health since 2001.

Adel Mahmoud, M.D., Ph.D., 60, president, Merck Vaccines since 1999.

MORE
Board of Directors
Board of Directors
Left to right,

William G. Bowen, Ph.D., 68, president of The Andrew W. Mellon Foundation.

Heidi G. Miller, Ph.D., 48, vice chairman of Marsh Inc.

Samuel O. Thier, M.D., 64,
president, chief executive officer and a director of Partners HealthCare System, Inc.

Edward M. Scolnick, M.D., 61, executive vice president, science and technology, and president, Merck Research Laboratories.
Anne M. Tatlock, 62, chairman and chief executive officer of Fiduciary Trust Company International and vice-chairman of Franklin Resources, Inc.

Raymond V. Gilmartin, 61, chairman, president and chief executive officer of Merck since 1994.

Johnnetta B. Cole, Ph.D., 65, retired Presidential Distinguished Professor, Emory University.

Lawrence A. Bossidy, 67, chairman of Honeywell International Inc.
Niall FitzGerald, 56, chairman of Unilever PLC and vice chairman of Unilever NV.

Thomas E. Shenk, Ph.D., 55, Elkins professor and chairman of the department of molecular biology at Princeton University.

William B. Harrison, Jr., 58, chairman and chief executive officer of J.P. Morgan Chase & Co.

William N. Kelley, M.D., 62, professor of medicine, biochemistry and biophysics, University of Pennsylvania School of Medicine.

MORE
14 of 15
Previous Cover Next
Profile Financial Highlights Products Letter Breakthroughs Caring Financials Management Corporate Info
Merck Annual Report 2001
Copyright © 1995-2002 Merck & Co., Inc., Whitehouse Station, NJ, USA. All rights reserved.